Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.68 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.56 |
| ▸ | DRD3 | P35462 | 4/20 | 0.56 |
| ▸ | DRD2 | P14416 | 3/20 | 0.56 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | THRA | P10827 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trolamine SCHEMBL11590482 | 1.00 | KCNH2 (0.68) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| Trolamine SCHEMBL28434418 | 0.98 | KCNH2 (0.66) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| Trolamine SCHEMBL691941 | 0.92 | KCNH2 (0.59) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| Butane SCHEMBL23824784 | 0.89 | KCNH2 (0.61) | KCNH2SIGMAR1ADRA2ASLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL5053406 | 0.89 | OPRM1 (0.68) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| SCHEMBL11134742 | 0.87 | KCNH2 (0.86) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| SCHEMBL11237058 | 0.87 | KCNH2 (0.86) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| SCHEMBL8086575 | 0.87 | KCNH2 (0.59) | KCNH2OPRM1DRD3SIGMAR1ADRA2A | |
| SCHEMBL11135856 | 0.87 | KCNH2 (0.86) | KCNH2OPRM1DRD3DRD2OPRD1 | |
| SCHEMBL29107066 | 0.87 | KCNH2 (0.86) | KCNH2OPRM1DRD3DRD2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024072942-A2 | SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-04-04 | — | — | WO | claimed |
| US-20240101495-A1 | A SOLUBILIZING COMPOSITION | ORO AGRI INC. | 2024-03-28 | — | — | US | claimed |
| US-20230329987-A1 | Sulfate-Free Surfactant System | ETHOX CHEMICALS, LLC | 2023-10-19 | — | — | US | claimed |
| WO-2023180932-A1 | AGRICULTURAL COMPOSITION | ORO AGRI EUROPE, S.A. (PT) | 2023-09-28 | — | — | WO | claimed |
| EP-4204100-A1 | HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE | L'OREAL (FR) | 2023-07-05 | — | — | EP | claimed |
| US-11692107-B1 | Graffiti removal system | ETHOX CHEMICALS, LLC (US) | 2023-07-04 | — | — | US | claimed |
| US-20230172200-A1 | A LIQUID ANTI-PATHOGENIC AGRICULTURAL COMPOSITION | ORO AGRI INC. | 2023-06-08 | — | — | US | claimed |
| US-20230157280-A1 | A LIQUID AGRICULTURAL ADJUVANT | ORO AGRI INC. | 2023-05-25 | — | — | US | claimed |
| US-20230053399-A1 | AN AGRICULTURAL ADJUVANT | ORO AGRI INC. | 2023-02-23 | — | — | US | claimed |
| US-20230053407-A1 | Sulfate-Free Surfactant System | FIRST NATIONAL BANK OF PENNSYLVANIA | 2023-02-23 | — | — | US | claimed |
| WO-2009012546-A1 | BLOCKING COMPOSITION AGAINST FIRE ACTION AND ADVANCE IN DIVERSE SURFACES, MANUFACTURING AND APPLICATION PROCESS THEREOF | RADIX ASSESSORIA E CONSULTORIA LTDA. (BR) | 2009-01-29 | — | — | WO | claimed |
| US-20080233053-A1 | nebulizer; eye-state detector, open or shut; reversibly actuatable radiation-source of sterilizing radiation; contactor for posterior eye; shut eye; vibrate eyelid; increase bioavailability to sclera, optic nerve, retina, brain, central nervous system, cerebral cavity, cerebrospinal fluid, spinal cord | PHARMALIGHT INC. (DE) | 2008-09-25 | — | — | US | claimed |
| EP-1848541-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | Pharmalight Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2006082588-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | PHARMALIGHT INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-20020119113-A1 | SHAMPOO COMPOSITIONS | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-08-29 | — | — | US | claimed |
| EP-1126819-A1 | SHAMPOO COMPOSITIONS | UNILEVER PLC (GB) | 2001-08-29 | — | — | EP | claimed |
| EP-0586519-B1 | METHOD OF TREATING SOIL | SOTAC CORP (US) | 2000-09-13 | — | — | EP | claimed |
| WO-2000025741-A1 | SHAMPOO COMPOSITIONS | UNILEVER PLC (GB) | 2000-05-11 | — | — | WO | claimed |
| US-5523081-A | MIXTURE OF WATER, SOAP AND POLYSILOXANE MICROEMULSION | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1996-06-04 | — | — | US | claimed |
| US-4272495-A | Chemical processes | WOODSREEF MINES LIMITED (AU) | 1981-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329987-A1 | Sulfate-Free Surfactant System | STS, DLST, MPST | KCNH2 2600/4885OPRM1 3657/4885DRD3 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.